EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Left Subclavian Artery Management During TEVAR: Medico-Legal Challenges of Physician-Modified Endografts

Pasqualino Sirignano, Giulia Colonna, Liliana Iannelli, Mario Marino, Cesare Battocchio, Luigi Rizzo, Giovanna Ricci

Acta Aorta · 05.11.2026

DOI: 10.1055/a-2974-3879 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Aorta, online erschienen am 05.11.2026. Verfasst von Pasqualino Sirignano und 6 weiteren Autor:innen. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Management of the left subclavian artery (LSA) during thoracic endovascular aortic repair (TEVAR) requires integration of anatomical, neurologic, procedural, and patient-related factors and may raise medico-legal concerns, particularly with intentional LSA coverage, revascularization, or physician-modified endografts (PMEGs). This article examines the main medico-legal and regulatory issues related to LSA management, including device instructions for use (IFU), off-label use, physician modification, professional competence, institutional governance, product liability, informed consent, and documentation. The European regulatory framework, particularly Regulation (EU) 2017/745, is considered alongside principles of professional liability and patient autonomy. Regulatory compliance should be distinguished from the clinical standard of care, as neither treatment within the IFU nor off-label use alone determines the appropriateness of a clinical decision. In innovative strategies, informed consent should address uncertainties, benefits, alternatives, and risks, while medical records should document the rationale for treatment. A patient-specific, evidence-informed, and well-documented approach is essential to balance innovation, patient safety, and medico-legal responsibility.

Zitieren

APA

Sirignano, P., Colonna, G., Iannelli, L., Marino, M., Battocchio, C., Rizzo, L., & Ricci, G. (2026). Left Subclavian Artery Management During TEVAR: Medico-Legal Challenges of Physician-Modified Endografts. Acta Aorta. https://doi.org/10.1055/a-2974-3879

Vancouver

Sirignano P, Colonna G, Iannelli L, Marino M, Battocchio C, Rizzo L, et al. Left Subclavian Artery Management During TEVAR: Medico-Legal Challenges of Physician-Modified Endografts. Acta Aorta. 2026. doi:10.1055/a-2974-3879

BibTeX
@article{Sirignano2026,
  author = {Sirignano, Pasqualino and Colonna, Giulia and Iannelli, Liliana and Marino, Mario and Battocchio, Cesare and Rizzo, Luigi and Ricci, Giovanna},
  title = {Left Subclavian Artery Management During TEVAR: Medico-Legal Challenges of Physician-Modified Endografts},
  journal = {Acta Aorta},
  year = {2026},
  doi = {10.1055/a-2974-3879}
}
Kostenlos starten →